National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           
Last Modified: 7/30/2008     First Published: 6/9/2006  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


NCI, Pharmaceutical / Industry


ROLL-GUP-0205-1
UCLA-0507059-01, NCT00336934


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Active


18 and over


Other


Dietary intervention FL
NCT00455416


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Other


GUP-0205-1XX
NCT00732043


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Treatment


Active


18 and over


Other


2006-0220
NCT00413530

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov